Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
WHO ‘strongly’ against hydroxychloroquine use for COVID-19 prevention
As Sabaa promises the best quality every step of the way, we offer medicine trials at our state-of-the-art facility.
Get a quotation below:
© 2021 All Rights Reserved. Designed & Developed By Spark Systems